Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/32646
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStordal, B-
dc.contributor.authorHarvie, M-
dc.contributor.authorAntoniou, MN-
dc.contributor.authorBellingham, M-
dc.contributor.authorChan, DSM-
dc.contributor.authorDarbre, P-
dc.contributor.authorKarlsson, O-
dc.contributor.authorKortenkamp, A-
dc.contributor.authorMagee, P-
dc.contributor.authorMandriota, S-
dc.contributor.authorSilva, E-
dc.contributor.authorTurner, JE-
dc.contributor.authorVandenberg, LN-
dc.contributor.authorEvans, DG-
dc.date.accessioned2026-01-14T17:45:55Z-
dc.date.available2026-01-14T17:45:55Z-
dc.date.issued2024-09-24-
dc.identifierORCiD: Britta Stordal https://orcid.org/0000-0002-7892-951X-
dc.identifierORCiD: Andreas Kortenkamp https://orcid.org/0000-0001-9055-9729-
dc.identifierORCiD: Elisabete Silva https://orcid.org/0000-0001-8444-2452-
dc.identifierArticle number: e70255-
dc.identifier.citationStordal, D. et al. (2024) 'Breast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conference', Cancer Medicine, 2024, 13 (18), e70255, pp. 1 - 11. doi: 10.1002/cam4.70255.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/32646-
dc.descriptionData Availability Statement: Not applicable.en_US
dc.description.abstractThe Breast Cancer UK—Breast Cancer Prevention Conference addressed risk from environmental pollutants and health behaviour-related breast-cancer risk. Epidemiological studies examining individual chemicals and breast cancer risk have produced inconclusive results including endocrine disrupting chemicals (EDCs) Bisphenol A, per- and polyfluorinated alkyl substances as well as aluminium. However, laboratory studies have shown that multiple EDCs, can work together to exhibit effects, even when combined at levels that alone are ineffective. The TEXB-α/β assay measures total estrogenic load, and studies have provided evidence of a link between multiple-chemical exposures and breast cancer. However, prospective studies using TEXB-α/β are needed to establish a causative link. There is also a need to assess real-life exposure to environmental-chemical mixtures during pregnancy, and their potential involvement in programming adverse foetal health outcomes in later life. Higher rates of breast cancer have occurred alongside increases in potentially-modifiable risk factors such as obesity. Increasing body-mass index is associated with increased risk of developing postmenopausal breast cancer, but with decreased risk of premenopausal breast cancer. In contrast, lower rates of breast cancer in Asian compared to Western populations have been linked to soya/isoflavone consumption. Risk is decreased by breastfeeding, which is in addition to the decrease in risk observed for each birth and a young first-birth. Risk is lower in those with higher levels of self-reported physical activity. Current evidence suggests breast-cancer survivors should also avoid weight gain, be physically active, and eat a healthy diet for overall health. A broad scientific perspective on breast cancer risk requires focus on both environmental exposure to chemicals and health behaviour-related risk. Research into chemical exposure needs to focus on chemical mixtures and prospective epidemiological studies in order to test the effects on breast cancer risk. Behaviour-related research needs to focus on implementation as well as deeper understanding of the mechanisms of cancer prevention.en_US
dc.description.sponsorshipBreast Cancer UK as the funder of the Breast Cancer Prevention Conference at Middlesex University in June 2023. D Gareth Evans is supported by the NIHR Manchester Biomedical Research Centre (IS-BRC-1215-20007) and Cancer Research UK ACED Alliance Early Detection Centre C19941/A27859.en_US
dc.format.extent1 - 11-
dc.format.mediumElectronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherWieyen_US
dc.rightsCreative Commons Attribution 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectaluminiumen_US
dc.subjectbreast canceren_US
dc.subjectbreastfeedingen_US
dc.subjectendocrine disrupting chemicalsen_US
dc.subjectepidemiologyen_US
dc.subjectexerciseen_US
dc.subjecthealth behaviouren_US
dc.subjectpregnancy exposureen_US
dc.subjectpreventionen_US
dc.subjectrisken_US
dc.subjectweighten_US
dc.titleBreast cancer risk and prevention in 2024: An overview from the Breast Cancer UK - Breast Cancer Prevention Conferenceen_US
dc.typeArticleen_US
dc.date.dateAccepted2024-09-12-
dc.identifier.doihttps://doi.org/10.1002/cam4.70255-
dc.relation.isPartOfCancer Medicine-
pubs.issue18-
pubs.publication-statusPublished-
pubs.volume13-
dc.identifier.eissn2045-7634-
dc.rights.licensehttps://creativecommons.org/licenses/by/4.0/legalcode.en-
dcterms.dateAccepted2024-09-12-
dc.rights.holderThe Author(s)-
dc.contributor.orcidStordal, Britta [0000-0002-7892-951X]-
dc.contributor.orcidKortenkamp, Andreas [0000-0001-9055-9729]-
dc.contributor.orcidSilva, Elisabete [0000-0001-8444-2452]-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.730.35 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons